Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Bispectral Index During Remimazolam and Propofol Sedation
ChiCTR2500112548Phase 4Not yet recruiting
- Sponsor
- Sanming First Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam and propofol in sedation (2 arms), sponsored by Sanming First Hospital. Primary endpoint: Bispectral index during deep sedation. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
sedation
Beyond the preview
Go deeper on ChiCTR2500112548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112548.